Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Peoria. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Peoria at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to physician's choice of chemotherapy (doxorubicin or paclitaxel) in participants with B7-H4 selected advanced/metastatic EC that progressed following platinum based chemotherapy and anti-PD-1/anti-PD-L1 therapy.
Sponsor: AstraZeneca
Check if you qualify for this endometrial cancer clinical trial in Peoria, IL
If you're searching for endometrial cancer treatment options in Peoria, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Peoria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.